ArticleVaccines2022

A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis.

Matthew M Hille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.